REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Obsurge Biotech Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Obsurge Biotech Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Obsurge Biotech Limited is an unlisted company, incorporated on 04/01/2002. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL2002PLC113701 and registration number is 113701. The company is a trade company, it is engaged in wholesale trading.

Legal Address
101-102 Aditya Tower District Centre Laxmi Nagar
East Delhi; Delhi; Postal Code: 110092

Contact Details: Purchase the Obsurge Biotech Limited report to view the information.

Website: http://www.obsurge.com

Basic Information
Total Employees:
Purchase the Obsurge Biotech Limited report to view the information.
Outstanding Shares:
Purchase the Obsurge Biotech Limited report to view the information.
Registered Capital:
Purchase the Obsurge Biotech Limited report to view the information.
Incorporation Date:
January 04, 2002
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
91.83%
Purchase this report to view the information.
2.13%
Company Performance
Financial values in the chart are available after Obsurge Biotech Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.02%▲
Total operating revenue
10.3%▲
Operating profit (EBIT)
-39.31%▼
EBITDA
-35.12%▼
Net Profit (Loss) for the Period
-40.01%▼
Total assets
15.03%▲
Total equity
19.16%▲
Operating Profit Margin (ROS)
-5.73%▼
Net Profit Margin
-4.28%▼
Return on Equity (ROE)
-15.86%▼
Debt to Equity Ratio
3.24%▲
Quick Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo